These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4618541)

  • 41. Haptoglobin in splenomegalic cirrhosis; report of 40 patients after shunts and or splenectomy.
    Andreuzzi P; Vai C; Santese R; Andreuzzi B; Cantoni L
    Panminerva Med; 1983; 25(2):99-104. PubMed ID: 6646799
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical nutrition of patients surgically treated by vascular shunts for portal hypertension].
    Balzola F; Domeniconi D; Palmo A; Bianco L; Boggio Bertinet D; Zoppè L
    Minerva Med; 1978 Apr; 69(17):1183-6. PubMed ID: 662147
    [No Abstract]   [Full Text] [Related]  

  • 43. Portacaval shunt as emergency procedure in unselected patients with alcoholic cirrhosis.
    Orloff MJ; Charters AC; Chandler JG; Condon JK; Grambort DE; Modafferi TR; Levin SE; Brown NB; Sviokla SC; Knox DG
    Surg Gynecol Obstet; 1975 Jul; 141(1):59-68. PubMed ID: 1154215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Indication for portacaval anastomosis].
    Hamelmann H; Nitschke J
    Dtsch Med Wochenschr; 1971 May; 96(22):957-9. PubMed ID: 5578598
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatic circulatory and functional alterations following side-to-side portacaval shunt.
    Mulder DG; Plested WG; Hanafee WN; Murray JF
    Surgery; 1966 Jun; 59(6):923-31. PubMed ID: 5937966
    [No Abstract]   [Full Text] [Related]  

  • 46. [Our judgements on the potential for surgical treatment of patients with liver cirrhosis and portal hypertension].
    Tsatsanidi KN; Eramishantsev AK; Korshunov IB
    Ter Arkh; 1988; 60(10):26-30. PubMed ID: 3265545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Characteristics of portal-lymphatic hypertension and surgical treatment of patients with cirrhosis of the liver and persistent ascites].
    Nazyrov FG; Khoroshaev VA; Deviatov AV; Vakhidov AV
    Vestn Khir Im I I Grek; 1989 Feb; 142(2):104-6. PubMed ID: 2728224
    [No Abstract]   [Full Text] [Related]  

  • 48. [Transjugular intrahepatic portacaval shunt. Preliminary results].
    Perarnau JM; Raabe JJ; Schwing D; Rucin B; Monchovet S; Rössle M; Arbogast J
    Gastroenterol Clin Biol; 1993; 17(6-7):422-30. PubMed ID: 8243926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Surgical treatment of portal hypertension accompanied by ascites].
    Lytkin MI; Eriukhin IA; Zubarev PN
    Klin Med (Mosk); 1979 Nov; 57(11):38-41. PubMed ID: 544905
    [No Abstract]   [Full Text] [Related]  

  • 50. [Portacaval shunt associated with arterialization of portal vein: an experimental study in cirrhotic rats].
    Yang GS
    Zhonghua Wai Ke Za Zhi; 1983 Dec; 21(12):724-7. PubMed ID: 6676026
    [No Abstract]   [Full Text] [Related]  

  • 51. [Elective surgery of portal hypertension in the bleeding cirrhotic patient. Present status].
    Seco Gil JL; Molina Esteban J
    Rev Clin Esp; 1976 Mar; 140(6):589-94. PubMed ID: 1273361
    [No Abstract]   [Full Text] [Related]  

  • 52. [Portal hypertension. Reno-portal anastomosis].
    Pataro VF; Alche S; Trainini J
    Angiologia; 1976; 28(4):169-74. PubMed ID: 952422
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of portal hypertension].
    Mosimann R
    Helv Chir Acta; 1975 Mar; 42(1-2):267-85. PubMed ID: 1094012
    [No Abstract]   [Full Text] [Related]  

  • 54. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial.
    Rosemurgy AS; Frohman HA; Teta AF; Luberice K; Ross SB
    J Am Coll Surg; 2012 Apr; 214(4):445-53; discussion 453-5. PubMed ID: 22463885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Surgery of portal hypertension].
    Hivet M
    Cah Med; 1970 Sep; 11():Suppl:1-5. PubMed ID: 5454619
    [No Abstract]   [Full Text] [Related]  

  • 56. [Bleeding esophageal varices and their treatment. II. By-pass anastomosis for the reduction of portal hypertension].
    Hoffmann E; Jünemann A; Niemann F; Schröder R
    Zentralbl Chir; 1971 Jan; 96(3):70-91. PubMed ID: 4929635
    [No Abstract]   [Full Text] [Related]  

  • 57. Indications and operative results in 200 porta-caval shunt-operations.
    Schriefers KH
    J Cardiovasc Surg (Torino); 1966; 7(6):485-9. PubMed ID: 5958434
    [No Abstract]   [Full Text] [Related]  

  • 58. Surgical management of portal hypertension.
    Collins JC; Sarfeh IJ
    West J Med; 1995 Jun; 162(6):527-35. PubMed ID: 7618313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combined use of peritoneo-atrial shunting and endoscopic sclerotherapy of esophageal varicose veins in treating liver cirrhosis with portal hypertension and resistant ascites].
    Vakhidov AV; Nazyrov FG; Strusskiĭ LP; Akilov KhA; Deviatov AV; Asabaev ASh
    Klin Khir (1962); 1990; (9):3-5. PubMed ID: 2273775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hepatic hemodynamics before and after shunt operation].
    Leger L; Lemaigre G; Mouktar M
    Actual Hepatogastroenterol (Paris); 1968; 4(3):B77-94. PubMed ID: 5753104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.